Atrium Therapeutics, Inc.
RNA
$10.51
-$0.84-7.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.47% | -- | -- | ||
| Total Receivables | -- | 14,900.00% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 74.79% | 67.95% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 4,715.22% | -88.60% | -- | ||
| Total Current Assets | -3.68% | 9,937.43% | -- | ||
|
|
|||||
| Total Current Assets | -3.68% | 9,937.43% | -- | ||
| Net Property, Plant & Equipment | -16.07% | 15.83% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -74.46% | -- | -- | ||
| Total Assets | -4.05% | 3,400.06% | -- | ||
|
|
|||||
| Total Accounts Payable | 335.32% | -81.65% | -- | ||
| Total Accrued Expenses | 90.37% | 4.39% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -37.20% | -27.02% | -- | ||
| Total Finance Division Other Current Liabilities | -3.27% | -62.68% | -- | ||
| Total Other Current Liabilities | -3.27% | -62.68% | -- | ||
| Total Current Liabilities | 43.84% | -47.60% | -- | ||
|
|
|||||
| Total Current Liabilities | 43.84% | -47.60% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -5.29% | 24.21% | -- | ||
| Total Liabilities | 13.18% | -18.03% | -- | ||
|
|
|||||
| Common Stock & APIC | 0.40% | 453.96% | -- | ||
| Retained Earnings | -166.44% | -- | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -8.34% | 473.29% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -8.34% | 473.29% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -8.34% | 473.29% | -- | ||
|
|
|||||